Valuation : RaySearch Laboratories AB

Market Cap 5.97B 625M 538M 504M 462M 861M 59.06B 868M 2.32B 30.18B 2.35B 2.29B 97.2B P/E 2026 *
22.2x
P/E 2027 * 17.8x
Enterprise Value 6.12B 641M 551M 518M 473M 884M 60.59B 891M 2.38B 30.96B 2.41B 2.35B 99.72B EV / Sales 2026 *
4.38x
EV / Sales 2027 * 3.66x
Free-Float
80.09%
Yield 2026 *
2.25%
Yield 2027 * 2.69%
1 day+0.25%
1 week-4.56%
Current month-2.04%
1 month+0.65%
3 months-20.87%
6 months-7.46%
Current year-22.08%
1 week 175.9
Extreme 175.9
183.6
1 month 172.8
Extreme 172.8
199.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
266.5
3 years 78.2
Extreme 78.2
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-4.56% - - 625M
+1.30%+0.80%+4.96%+31.31% 46.04B
+0.72%-4.15%-41.30%+138.94% 12.98B
-0.03%+1.67%-10.69%+68.24% 5.87B
-0.58%+3.35%+58.92% - 4.32B
+0.37%+3.61% - - 2.1B
+0.32%+4.22%+6.09%-38.96% 1.59B
+1.57%-4.17%-31.01% - 1.08B
+0.39%-0.97%+30.28%+149.76% 1.01B
-0.59%-3.47%+53.17%+59.85% 987M
Average +0.44%+1.20%+8.80%+68.19% 8.44B
Weighted average by Cap. +1.32%+0.44%-0.77%+55.41%

Financials

2026 *2027 *
Net sales 1.4B 146M 126M 118M 108M 202M 13.82B 203M 544M 7.06B 549M 537M 22.75B 1.63B 171M 147M 138M 126M 236M 16.15B 237M 635M 8.25B 641M 627M 26.58B
Net income 272M 28.48M 24.5M 22.99M 21.04M 39.26M 2.69B 39.58M 106M 1.38B 107M 105M 4.43B 338M 35.34M 30.4M 28.53M 26.1M 48.72M 3.34B 49.11M 131M 1.71B 133M 130M 5.5B
Net Debt 155M 16.23M 13.96M 13.1M 11.99M 22.37M 1.53B 22.55M 60.36M 784M 60.94M 59.61M 2.52B 7M 733K 631K 592K 541K 1.01M 69.28M 1.02M 2.73M 35.4M 2.75M 2.69M 114M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
26-09-04 SEK 178.05 +0.37% 0
26-09-03 SEK 177.90 +0.74% 1,650
26-09-02 SEK 176.60 -1.89% 2,008
26-09-01 SEK 180.00 -0.96% 1,147
26-08-31 SEK 181.75 -2.57% 390
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
177.50SEK
Average target price
297.50SEK
Spread / Average Target
+67.61%

Quarterly revenue - Rate of surprise